Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD.
Front Pharmacol
; 9: 258, 2018.
Article
in En
| MEDLINE
| ID: mdl-29719507